Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
APYX Apyx Medical	$2.09 +1.5%	$2.11	$0.76 ▼ $2.73	$79.04M	1.39	114,673 shs	36,763 shs
BDMD Baird Medical Investment	$2.30 +15.0%	$3.41	$1.05 ▼ $12.50	$82.18M	-1	333,700 shs	419,459 shs
GTHP Guided Therapeutics	$0.26 -1.2%	$0.24	$0.06 ▼ $0.32	$21.11M	0.18	13,853 shs	2,068 shs
VANI Vivani Medical	$1.24 +2.5%	$1.35	$0.91 ▼ $1.80	$73.46M	2.99	106,198 shs	29,216 shs

7 Energy Stocks to Buy and Hold Forever

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
APYX Apyx Medical	+1.48%	-2.83%	-8.44%	+33.77%	+67.48%
BDMD Baird Medical Investment	-2.44%	-22.48%	-7.83%	-59.18%	+199,999,900.00%
GTHP Guided Therapeutics	-9.83%	+4.81%	+13.19%	+90.00%	+180.00%
VANI Vivani Medical	-0.82%	-4.72%	-22.44%	+7.08%	-12.95%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
APYX Apyx Medical	1.2861 of 5 stars	0.0	3.0	0.0	4.2	0.6	1.7	0.6
BDMD Baird Medical Investment	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
GTHP Guided Therapeutics	0.5608 of 5 stars	0.0	3.0	0.0	0.0	2.0	1.7	0.0
VANI Vivani Medical	2.4431 of 5 stars	3.5	3.0	0.0	0.0	2.3	1.7	0.0

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
APYX Apyx Medical	2.67	Moderate Buy	N/A	N/A
BDMD Baird Medical Investment	0.00	N/A	N/A	N/A
GTHP Guided Therapeutics	0.00	N/A	N/A	N/A
VANI Vivani Medical	3.00	Buy	$4.00	222.58% Upside

Current Analyst Ratings Breakdown

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
APYX Apyx Medical	$48.10M	1.64	N/A	N/A	$0.20 per share	10.45
BDMD Baird Medical Investment	N/A	N/A	N/A	N/A	N/A	N/A
GTHP Guided Therapeutics	$10K	2,110.56	N/A	N/A	($0.10) per share	-2.63
VANI Vivani Medical	N/A	N/A	N/A	N/A	$0.08 per share	N/A

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
APYX Apyx Medical	-$23.46M	-$0.45	N/A	N/A	N/A	-37.11%	-158.22%	-28.30%	11/7/2025 (Estimated)
BDMD Baird Medical Investment	N/A	N/A	0.00	∞	N/A	N/A	N/A	N/A	N/A
GTHP Guided Therapeutics	-$2.42M	-$0.05	N/A	∞	N/A	N/A	N/A	-219.85%	N/A
VANI Vivani Medical	-$23.49M	-$0.45	N/A	N/A	N/A	N/A	-194.66%	-68.64%	N/A

Latest GTHP, APYX, BDMD, and VANI Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/14/2025	Q2 2025	GTHP Guided Therapeutics	N/A	-$0.01	N/A	-$0.01	N/A	$0.12 million
8/13/2025	Q2 2025	VANI Vivani Medical	-$0.10	-$0.12	-$0.02	-$0.12	N/A	N/A
8/7/2025	Q2 2025	APYX Apyx Medical	-$0.0933	-$0.09	+$0.0033	-$0.09	$11.69 million	$11.37 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
APYX Apyx Medical	N/A	N/A	N/A	N/A	N/A
BDMD Baird Medical Investment	N/A	N/A	N/A	N/A	N/A
GTHP Guided Therapeutics	N/A	N/A	N/A	N/A	N/A
VANI Vivani Medical	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
APYX Apyx Medical	4.61	4.72	3.95
BDMD Baird Medical Investment	N/A	N/A	N/A
GTHP Guided Therapeutics	N/A	0.13	0.03
VANI Vivani Medical	N/A	1.30	1.30

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
APYX Apyx Medical	55.33%
BDMD Baird Medical Investment	19.78%
GTHP Guided Therapeutics	9.69%
VANI Vivani Medical	6.78%

Insider Ownership

Company	Insider Ownership
APYX Apyx Medical	15.20%
BDMD Baird Medical Investment	78.90%
GTHP Guided Therapeutics	66.83%
VANI Vivani Medical	46.40%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
APYX Apyx Medical	270	37.82 million	32.07 million	Optionable
BDMD Baird Medical Investment	N/A	35.73 million	7.54 million	N/A
GTHP Guided Therapeutics	5	80.28 million	26.63 million	Not Optionable
VANI Vivani Medical	20	59.24 million	31.76 million	Optionable

GTHP, APYX, BDMD, and VANI Headlines

Recent News About These Companies

Are weight-loss jabs for dogs the next big thing? Scientists exploring new solutions for pet obesity

August 22 at 10:49 AM | msn.com

Ozempic For Pets: New Drug Being Tested For Animal Obesity - Here's What We Know

August 22 at 10:49 AM | msn.com

Could Dogs Get Their Version Of Ozempic? Scientists Test "Ozempup" For Pet Obesity

August 21 at 11:28 AM | ndtv.comN

After Ozempic, is “Ozempup” on the way? Scientists explore weight-loss jabs for obese pet dogs-- All details here

August 21 at 3:54 AM | msn.com

Vivani Medical, Inc. to Present at H.C. Wainwright 27th Annual Global Investment Conference on Innovative Drug Implant Technology

August 20 at 8:51 AM | quiverquant.comQ

Vivani Medical CEO Adam Mendelsohn to Present at the H.C. Wainwright 27th Annual Global Investment Conference on September 10, 2025

August 20 at 8:30 AM | globenewswire.com

Fido get fat? Ozempic for dogs could hit the market in three years

August 19 at 7:29 PM | msn.com

Vivani Medical (NASDAQ:VANI) Stock Price Down 0.8% After Earnings Miss

August 15, 2025 | marketbeat.com

Vivani Medical (NASDAQ:VANI) Announces Quarterly Earnings Results

August 15, 2025 | marketbeat.com

Vivani closes $10M financing, advances GLP-1 implant

August 14, 2025 | drugdeliverybusiness.comD

Vivani Medical, Inc.: Vivani Medical Provides Business Update Including $10M Equity Financing and Reports Second Quarter 2025 Financial Results

August 14, 2025 | finanznachrichten.de

Vivani Medical (NASDAQ:VANI) Stock Price Down 0.8% Following Weak Earnings

August 14, 2025 | americanbankingnews.com

Vivani Medical Reports Q2 2025 Results and $10M Financing

August 13, 2025 | tipranks.com

Vivani Medical Provides Business Update Including $10M Equity Financing and Reports Second ...

August 13, 2025 | bakersfield.comB

Vivani Medical Secures $10M Through Share Purchase Agreement

August 13, 2025 | msn.com

Vivani Medical Provides Business Update Including $10M Equity Financing and Reports Second Quarter 2025 Financial Results

August 13, 2025 | globenewswire.com

Vivani Medical (VANI) to Release Quarterly Earnings on Tuesday

August 6, 2025 | marketbeat.com

Vivani Medical, Inc. (NASDAQ:VANI) Sees Large Growth in Short Interest

August 2, 2025 | marketbeat.com

Vivani Medical (NASDAQ:VANI) Shares Up 0.6% - Here's What Happened

July 23, 2025 | marketbeat.com

3 Penny Stocks With Market Caps Over $30M To Consider

July 16, 2025 | finance.yahoo.com

Vivani Medical Insiders Added US$5.29m Of Stock To Their Holdings

June 30, 2025 | uk.finance.yahoo.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

GTHP, APYX, BDMD, and VANI Company Descriptions

Apyx Medical NASDAQ:APYX

$2.09 +0.03 (+1.46%)

Closing price 04:00 PM Eastern

Extended Trading

$2.09 0.00 (0.00%)

As of 04:27 PM Eastern

Apyx Medical Corporation, an energy technology company, engages in the design, development, and manufacture of medical devices in the United States and internationally. The company operates through two segments: Advanced Energy and Original Equipment Manufacturing (OEM). It offers Helium Plasma Generator for delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures. The company's Helium Plasma Technology products are marketed and sold under the Renuvion name in the cosmetic surgery market and under the J-Plasma name in the hospital surgical market. It also develops and manufactures various hand pieces for open and laparoscopic procedures; and OEM generators, as well as related accessories. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.

Baird Medical Investment NASDAQ:BDMD

$2.30 +0.30 (+15.00%)

As of 04:00 PM Eastern

Baird Medical Investment Holdings Ltd. is a medical technology company, which engages in the development and provision of medical devices. It is also involved in the design, development, manufacturing, and sale of microwave ablation medical devices, as well as sale of other medical devices. The company was founded on June 16, 2023 and is headquartered in Guangzhou, China.

Guided Therapeutics OTCMKTS:GTHP

$0.26 0.00 (-1.17%)

As of 03:59 PM Eastern

Guided Therapeutics, Inc., a medical technology company, focuses on developing medical devices. It focuses on the commercialization of LuViva, a non-invasive cervical cancer detection device that identifies cervical cancers and precancers painlessly, non-invasively, and at the point-of-care by scanning the cervix with light, then analyzing the light reflected and fluorescent light. The company was formerly known as SpectRx, Inc. and changed its name to Guided Therapeutics, Inc. in February 2008. Guided Therapeutics, Inc. was incorporated in 1992 and is based in Norcross, Georgia.

Vivani Medical NASDAQ:VANI

$1.24 +0.03 (+2.48%)

Closing price 04:00 PM Eastern

Extended Trading

$1.24 0.00 (-0.40%)

As of 04:10 PM Eastern

Vivani Medical, Inc., a clinical stage company, develops various implants that treat chronic diseases with high unmet medical need. It engages in developing a portfolio of miniature drug implants to deliver minimally fluctuating drug profiles; and implantable visual prostheses devices to deliver useful artificial vision to blind individuals. The company is headquartered in Emeryville, California.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time